The anticipated arrival of two new vaccines can boost the morale of those worried about the wait for their dose.
Academic rigour, journalistic flair
Articles on Vaccine supply chains
Displaying all articles
Supply chain issues can be addressed – but the issues with the AstraZeneca vaccine are political, too.
Getting a vaccine is proving difficult for many older people now, but the mad rush for the vaccine won't last long. Many people don't want to get one at all, and that will impede herd immunity.
The vaccines' cold storage requirements and shipment rules put small, rural communities at a disadvantage, but that's only part of a long-running challenge.
Top contributors
-
Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Reader in Health Service Operations, University of Bradford
-
Assistant Professor, Texas A&M University School of Public Health, Texas A&M University
-
Assistant Professor of Political Science, Oklahoma State University
-
Senior Lecturer in Supply Chain Management, Liverpool John Moores University
-
Head of School of Management and Professor of Technology Management and Circular Economy, University of Bradford
-
Professor of Rural Nursing, Binghamton University, State University of New York
-
Clinical Assistant Professor, Pharmacy Practice, Binghamton University, State University of New York
-
Associate Dean (International and Accreditations), Professor of Circular Economy, University of Bradford
